Glutamate-based therapeutic approaches: Inhibitors of glycine transport

Current Opinion in Pharmacology

Volumn 6, Issue 1 SPEC. ISS., 2006, Pages 75-81

  Lechner, Sandra M ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ALX 5407; CLOZAPINE; DEXAMPHETAMINE; DEXTRO SERINE; DIZOCILPINE; FLUOXETINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GLYCINE; GLYCINE RECEPTOR; GLYCINE RECEPTOR ANTAGONIST; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; JNJ 17305600; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; ORG 24461; ORG 24462; ORG 24598; ORG 25543; PHENCYCLIDINE; RISPERIDONE; SARCOSINE; SSR 504734; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID TRANSPORT; ATAXIA; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EXCITOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOTOR DYSFUNCTION; NERVE CELL EXCITABILITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; PSYCHOSIS; RESPIRATORY TRACT DISEASE; REVIEW; SCHIZOPHRENIA; SYNAPTIC INHIBITION; TRANSGENIC MOUSE;

EID: 30844469281     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.11.002     Document Type: Review

References (57)

1. H. Betz Ligand-gated ion channels in the brain: The amino acid receptor superfamily Neuron 5 1990 383-392
2. R. Bergeron T.M. Meyer J.T. Coyle R.W. Greene Modulation of N-methyl- d -aspartate receptor function by glycine transport Proc Natl Acad Sci USA 95 1998 15730-15734
3. W. Danysz A.C. Parsons Glycine and N-methyl- d -aspartate receptors: physiological significance and possible therapeutic applications Pharmacol Rev 50 1998 597-664
4. B. Borowsky E. Mezey B.J. Hoffman Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene Neuron 10 1993 851-863
5. A. Slassi I. Egle Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases Expert Opin Ther Patents 14 2004 201-214
6. C. Sur G.G. Kinney The therapeutic potential of glycine transporter-1 inhibitors Expert Opin Investig Drugs 13 2004 515-521
7. D.C. Javitt Glutamate as a therapeutic target in psychiatric disorders Mol Psychiatry 9 2004 984-997
8. D.C. Javitt A. Balla S. Burch et al. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl- d -aspartate receptor/ glycine-site agonists Neuropsychopharmacol 29 2004 300-307
9. D.C. Javitt A. Hashim H. Sershen Modulation of striatal dopamine release by glycine transport inhibitors Neuropsychopharmacol 30 2005 649-656
10. M. Leonetti C. Desvignes I. Bougault J. Souilhac F. Oury-Donat R. Steinberg 2-chloro-N-[(s)-phenyl [(2S)-piperidin-2-YL]methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission Neurosci 2005 [Epub ahead of print]
11. V. Eulenburg W. Armsen H. Betz J. Gomeza Glycine transporters: Essential regulators of neurotransmission Trends Biochem Sci 30 2005 325-333
12. K.M. Kim S.F. Kingsmore H. Han T.L. Yang-Feng N. Godinot M.F. Seldin M.G. Caron B. Giros Cloning of the human glycine transporter Type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene Mol Pharmacol 45 1994 608-617
13. J.A. Morrow I.T. Collie D.R. Dunbar G.B. Walker M. Shahid D.R. Hill Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localization of the gene in the human genome FEBS Lett 439 1998 334-340
14. N. Nelson The family of Na+/Cl- neurotransmitter transporters J Neurochem 71 1998 1785-1803
15. F. Zafra J. Gomeza L. Olivares C. Aragon C. Gimenez Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS Eur J Neurosci 7 1995 1342-1352
16. F. Zafra C. Aragon L. Olivares N.C. Danbolt C. Gimenez J. Storm-Mathisen Glycine transporters are differentially expressed among CNS cells J Neurosci 15 1995 3952-3969
17. B. Cubelos C. Gimenez F. Zafra Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain Cereb Cortex 15 2004 448-459
18. S. Supplisson C. Bergman Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes J Neurosci 17 1997 4580-4590
19. B.N. Atkinson S.C. Bell M. De Vivo L.R. Kowalski S.M. Lechner V.I. Ognyanov C.S. Tham C. Tsai J. Jia D. Ashton M.A. Klitenick ALX-5407: A potent, selective inhibitor of the hGlyT1 glycine transporter Mol Pharmacol 60 2001 1414-1420
20. K.R. Aubrey R.J. Vandenberg N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport Br J Pharmacol 134 2001 1429-1436
21. P.J. Mallorga J.B. Williams M. Jacobson R. Marques A. Chaudhary P.J. Conn D.J. Pettibone C. Sur Pharmacology and expression analysis of glycine transporter GlyT1 with
22. G. Smith T. Ruhland G. Mikkelsen K. Andersen C.T. Christoffersen L.H. Alifrangis A. Mork S.P. Wren N. Harris B.M. Wyman G. Brandt The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors Bioorg Med Chem Lett 14 2004 4027-4030
23. A. Brown I. Carlyle J. Clark W. Hamilton S. Gibson G. McGarry S. McEachen D. Rae S. Thorn G. Walker Discovery and SAR of Org 24598 - a selective glycine uptake inhibitor Bioorg Med Chem Lett 11 2001 2007-2009
24. J.A. Lowe III Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents Expert Opin Ther Patents 15 2005 1657-1662
25. R. Depoortere G. Dargazanli G. Estenne-Bouhtou A. Coste C. Lanneau C. Desvignes M. Poncelet M. Heaulme V. Santucci M. Decobert et al. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic Neuropsychopharmacol 2005 1-23
26. G.G. Kinney C. Sur M. Burno P.J. Mallorga J.B. Williams D.J. Figueroa M. Wittmann W. Lemaire P.J. Conn The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior J Neurosci 23 2003 7586-7591
27. L. Chen M. Muhlhauser C.R. Yang Glycine transporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo J Neurophysiol 89 2003 691-703
28. L.S. Kegeles A. Abi-Dargham Y. Zea-Ponce J. Rodenhiser-Hill J.J. Mann R.L. Van Heertum T.B. Cooper A. Carlsson M. Laruelle Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia Biol Psychiatry 48 2000 627-640
29. D.C. Javitt S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301-1308
30. M.J. Millan N-methyl- d -aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: A critical review Curr Drug Target CNS Neurol Disord 1 2002 191-213
31. J.W. Olney J.W. Newcomber N.B. Farber NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 1999 523-533
32. E. Toth A. Lajtha Antagonism of phencyclidine-induced hyperactivity by glycine in mice Neurochem Res 11 1986 393-400
33. D.C. Javitt H. Sershen A. Hashim A. Lajtha Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide Neuropsychopharmacol 134 1997 131-139
34. L.G. Harsing Jr. I. Gacsalyi G. Szabo E. Schmidt N. Sziray C. Sebban B. Tesolin-Decros P. Matyus A. Egyed M. Spedding G. Levay The glycine transporter-1 inhibitors NFPS and ORG-24461: A pharmacological study Pharmacol Biochem Behav 74 2003 811-825
35. D.C. Javitt I. Zylberman S.R. Zukin U. Heresco-Levy J.P. Lindenmayer Amelioration of negative symptoms in schizophrenia by glycine Am J Psychiatry 151 1994 1234-1236
36. U. Heresco-Levy D. Javitt M. Ermilov C. Mordel A. Horowitz D. Kelly Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia Br J Psychiatry 169 1996 610-617
37. U. Heresco-Levy D.C. Javitt M. Ermilov G. Silipo J. Shimoni Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia Int J Neuropsychopharmacol 1 1998 131-136
38. G. Tsai P. Yang L.C. Chung N. Lange J.T. Coyle D-serine added to antipsychotics for the treatment of schizophrenia Biol Psychiatry 44 1998 1081-1089
39. D.C. Javitt G. Silipo A. Cienfuegos A.M. Shelley N. Bark M. Park J.P. Lindenmayer R. Suckow S.R. Zukin Adjunctive high-dose glycine in the treatment of schizophrenia Int J Neuropsychopharmacol 4 2001 385-391
40. U. Heresco-Levy M. Ermilov P. Lichtenberg G. Bar D.C. Javitt High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia Biol Psychiatry 55 2004 165-171
41. S.G. Potkin Y. Jin B.G. Bunney J. Costa B. Gulasekaram Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia Am J Psychiatry 156 1998 145-147
42. G. Tsai P. Yang L.C. Chung N. Lange J.T. Coyle D-serine added to clozapine for the treatment of schizophrenia Am J Psychiatry 156 1999 1822-1825
43. U. Heresco-Levy D.C. Javitt Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: A retrospective analysis Schizophr Res 66 2004 89-96
44. J.B. Williams P.J. Mallorga P.J. Conn D.J. Pettibone C. Sur Effects of typical and atypical antipsychotics on human glycine transporters Schizophrenia Res 2004 103-112
45. D.C. Javitt L. Duncan A. Balla H. Sershen Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: Implications for mechanisms of action Mol Psychiatry 10 2005 276-286
46. G. Tsai H.-Y. Lane P. Yang M.-Y. Chong N. Lange Glycine transporter 1 inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia Biol Psychiatry 55 2004 452-456
47. A. Balla H. Sershen M. Serra R. Koneru D.C. Javitt Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release Neuropsychopharmacol 28 2003 34-44
48. A. Abi-Dargham R. Gil J. Krystal R.M. Baldwin J.P. Seibyl M. Bowers C.H. van Dyck D.S. Charney R.B. Innis M. Laruelle Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort Am J Psychiatry 155 1998 761-767
49. J.G. Howland P. Taepavarapruk A.G. Phillips Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats J Neurosci 22 2002 1137-1145
50. J. Gomeza S. Hulsmann K. Ohno V. Eulenburg K. Szoke D. Richter H. Betz Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition Neuron 40 2003 785-796
51. G. Tsai R.J. Ralph-Williams M. Martina R. Bergeron J. Berger-Sweeney K.S. Dunham Z. Jiang S.B. Caine J.T. Coyle Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype Proc Natl Acad Sci USA 101 2004 8485-8490
52. L. Gabernet M. Pauly-Evers C. Schwerdel M. Lentz H. Bluethmann K. Vogt D. Alberati H. Mohler D. Boison Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression Neurosci Lett 373 2005 79-84
53. C. Aragon B. Lopez-Corcuera Glycine transporters: Crucial roles of pharmacological interest revealed by gene deletion Trends Pharm Sci 26 2005 283-286
54. J. Gomeza K. Ohno S. Hulsmann W. Armsen V. Eulenburg D.W. Richter B. Laube H. Betz Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality Neuron 40 2003 797-806
55. R. Lim P. Hoang A.J. Berger Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motor neurons J Neurophysiol 92 2004 2530-2537
56. A. Bradaia R. Schlichter J. Trouslard Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord J Physiol 559 2004 169-186
57. D. Billups D. Attwell Active release of glycine or D-serine saturates the glycine site of NMDA receptors at the cerebellar mossy fibre to granule cell synapse Eur J Neurosci 18 2003 2975-8290